NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/30/2026
Back to search
Official data from USPTO
ENFLONSIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
06/30/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
12/19/2022
Registration date
06/30/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/30/2026
Last transaction
06/30/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/18/2025
First use in commerce
08/18/2025
Drawing code
4
Owner type
16
Owner location
Rahway, NJ, US
Examiner
FATHY, DOMINIC
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Merck Sharp & Dohme LLC
Representatives
Palak Mayani MERCK & CO., INC.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of bonecardiovascularcentral nervous systemdermatologicalendocrinehematologicalhepatologicalimmunologicalgastrointestinalgenitourinarygynecologicalmetabolicmusculoskeletalnephrologicalneurologicaloncologicalophthalmicpsychiatricpulmonaryrenalrespiratoryurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of RSV; Pharmaceutical preparations for the prevention and treatment of autoimmune diseasesasthmacancer and tumorschronic coughdiabeteshypertensioninsomniaintestinal infectionsskin disordersurinary incontinence; Pharmaceutical preparationsanti-bacterialsantibioticsanti-fungalsanti-infectivesanti-inflammatoriesanti-parasiticsantivirals; human vaccine preparations; Inhalers filled with pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/30/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/10/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/10/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/01/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/30/2026
EX4G
SOU EXTENSION 4 GRANTED
04/30/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/27/2026
EEXT
SOU TEAS EXTENSION RECEIVED
10/31/2025
EXT4
SOU EXTENSION 4 FILED
10/30/2025
IUAF
USE AMENDMENT FILED
10/29/2025
EISU
TEAS STATEMENT OF USE RECEIVED
10/29/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/15/2025
EX3G
SOU EXTENSION 3 GRANTED
06/04/2025
EXT3
SOU EXTENSION 3 FILED
06/04/2025
EEXT
SOU TEAS EXTENSION RECEIVED
06/04/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/03/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
01/13/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/13/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/13/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/13/2025
EX2G
SOU EXTENSION 2 GRANTED
11/21/2024
EXT2
SOU EXTENSION 2 FILED
11/20/2024
EEXT
SOU TEAS EXTENSION RECEIVED
11/20/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/13/2024
EX1G
SOU EXTENSION 1 GRANTED
06/10/2024
EXT1
SOU EXTENSION 1 FILED
06/10/2024
EEXT
SOU TEAS EXTENSION RECEIVED
06/09/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/26/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/31/2023
PUBO
PUBLISHED FOR OPPOSITION
10/31/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/21/2023
DOCK
ASSIGNED TO EXAMINER
09/20/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/22/2022
NWAP
NEW APPLICATION ENTERED
12/22/2022
Continuous trademark protection
Get notified about every new filing that threatens ENFLONSIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.